Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,298
archived clinical trials in
Insomnia Sleep Studies

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
411
mi
from 43215
Lafayette Hill, PA
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
411
mi
from 43215
Lafayette Hill, PA
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
618
mi
from 43215
Warwick, RI
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
618
mi
from 43215
Warwick, RI
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
377
mi
from 43215
Anderson, SC
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
377
mi
from 43215
Anderson, SC
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
1064
mi
from 43215
Austin, TX
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
1064
mi
from 43215
Austin, TX
Click here to add this to my saved trials
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
314
mi
from 43215
Fairfax, VA
Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Cross-over Study to Evaluate the Effects of GW679769 on Polysomnographic Sleep Recordings, Subjective Sleep Assessment, and Daytime Cognitive Function in Elderly and Non-elderly Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
314
mi
from 43215
Fairfax, VA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
1663
mi
from 43215
Glendale, AZ
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
1663
mi
from 43215
Glendale, AZ
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
1970
mi
from 43215
Glendale, CA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
1970
mi
from 43215
Glendale, CA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
980
mi
from 43215
Hallandale Beach, FL
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
980
mi
from 43215
Hallandale Beach, FL
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
992
mi
from 43215
Miami, FL
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
992
mi
from 43215
Miami, FL
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
457
mi
from 43215
Fayetteville, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
457
mi
from 43215
Fayetteville, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
566
mi
from 43215
Hinesville, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
566
mi
from 43215
Hinesville, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
412
mi
from 43215
Suwanee, GA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
412
mi
from 43215
Suwanee, GA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
105
mi
from 43215
Crestview Hills, KY
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
105
mi
from 43215
Crestview Hills, KY
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
801
mi
from 43215
Baton Rouge, LA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
801
mi
from 43215
Baton Rouge, LA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
797
mi
from 43215
New Orleans, LA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
797
mi
from 43215
New Orleans, LA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
635
mi
from 43215
Newton, MA
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
635
mi
from 43215
Newton, MA
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
408
mi
from 43215
Fayetteville, NC
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
408
mi
from 43215
Fayetteville, NC
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
851
mi
from 43215
Oklahoma City, OK
Click here to add this to my saved trials
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated:  4/14/2015
GSK Investigational Site
mi
from 43215
Clamart,
Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia
A Randomized, Double-blind, Placebo-controlled, Crossover Study to Evaluate the Effects of Morning Administration of GW679769 (10mg and 30 mg) on Polysomnograph Sleep Recordings, Subjective Sleep Assessment, Daytime Cognition and Psychomotor Function in Subjects With Primary Insomnia
Status: Enrolling
Updated: 4/14/2015
GSK Investigational Site
mi
from 43215
Clamart,
Click here to add this to my saved trials
Use of Armodafinil for Fatigue in Sarcoidosis
Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis
Status: Enrolling
Updated:  5/26/2015
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Use of Armodafinil for Fatigue in Sarcoidosis
Use of Armodafinil (R-modafinil) for Fatigue in Sarcoidosis
Status: Enrolling
Updated: 5/26/2015
University of Cincinnati
98
mi
from 43215
Cincinnati, OH
Click here to add this to my saved trials
Brain Energy and Cognition
Brain Energy and Cognition
Status: Enrolling
Updated:  5/29/2015
Usariem
627
mi
from 43215
Natick, MA
Brain Energy and Cognition
Brain Energy and Cognition
Status: Enrolling
Updated: 5/29/2015
Usariem
627
mi
from 43215
Natick, MA
Click here to add this to my saved trials
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated:  6/4/2015
University of California, San Diego
1926
mi
from 43215
San Diego, CA
The Impact of Arousal Threshold in Obstructive Sleep Apnea
The Impact of Arousal Threshold in Obstructive Sleep Apnea: Donepezil's Effects on the Arousal Threshold and on the Apnea Hypopnea Index
Status: Enrolling
Updated: 6/4/2015
University of California, San Diego
1926
mi
from 43215
San Diego, CA
Click here to add this to my saved trials
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Status: Enrolling
Updated:  6/22/2015
Connecticut Mental Health Center
537
mi
from 43215
New Haven, CT
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia
Status: Enrolling
Updated: 6/22/2015
Connecticut Mental Health Center
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated:  7/1/2015
BWH Division of Sleep Medicine
641
mi
from 43215
Boston, MA
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Fire Fighter Fatigue Management Program: Operation Healthy Sleep
Status: Enrolling
Updated: 7/1/2015
BWH Division of Sleep Medicine
641
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Study of the Insomnia in Patients With Low Back Pain
Double-blind, Placebo-controlled Study of the Safety and Efficacy of Eszopiclone in the Treatment of Insomnia in Patients With Chronic Low Back Pain
Status: Enrolling
Updated:  7/2/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Study of the Insomnia in Patients With Low Back Pain
Double-blind, Placebo-controlled Study of the Safety and Efficacy of Eszopiclone in the Treatment of Insomnia in Patients With Chronic Low Back Pain
Status: Enrolling
Updated: 7/2/2015
Duke Univ Med Ctr
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
Sleep Disruption and ICU Delirium: Delirium Assessment and Monitoring Combined With the Evaluation of Sleep Using the Sedline Brain Function Monitor.
Status: Enrolling
Updated:  7/13/2015
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Study of Sleep and Delirium in the Intensive Care Unit (ICU)
Sleep Disruption and ICU Delirium: Delirium Assessment and Monitoring Combined With the Evaluation of Sleep Using the Sedline Brain Function Monitor.
Status: Enrolling
Updated: 7/13/2015
University of California at San Francisco
2109
mi
from 43215
San Francisco, CA
Click here to add this to my saved trials
SleepTrackTXT Feasibility and Pilot Study
The Sleep Track Text Pilot Trial in Emergency Care Clinicians
Status: Enrolling
Updated:  7/14/2015
University of Pittsburgh Department of Emergency Medicine School of Medicine
165
mi
from 43215
Pittsburgh, PA
SleepTrackTXT Feasibility and Pilot Study
The Sleep Track Text Pilot Trial in Emergency Care Clinicians
Status: Enrolling
Updated: 7/14/2015
University of Pittsburgh Department of Emergency Medicine School of Medicine
165
mi
from 43215
Pittsburgh, PA
Click here to add this to my saved trials
Positive Airway Pressure for the Treatment of Asthma
Positive Airway Pressure for the Treatment of Asthma
Status: Enrolling
Updated:  7/20/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Positive Airway Pressure for the Treatment of Asthma
Positive Airway Pressure for the Treatment of Asthma
Status: Enrolling
Updated: 7/20/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated:  7/21/2015
Cleveland Sleep Research Center
117
mi
from 43215
Middleburg Heights, OH
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
The Effects of Milnacipran on Sleep Disturbance in Fibromyalgia
Status: Enrolling
Updated: 7/21/2015
Cleveland Sleep Research Center
117
mi
from 43215
Middleburg Heights, OH
Click here to add this to my saved trials
Combination Therapy to Treat Sleep Apnea
Combination Therapy for the Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated:  7/21/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Combination Therapy to Treat Sleep Apnea
Combination Therapy for the Treatment of Obstructive Sleep Apnea
Status: Enrolling
Updated: 7/21/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated:  7/28/2015
Child Psychopharmacology Institute
838
mi
from 43215
Fargo, ND
Actigraphic Analysis of Treatment Response
Actigraphic Analysis of Treatment Response in a Six Year Old Girl With Kabuki Syndrome
Status: Enrolling
Updated: 7/28/2015
Child Psychopharmacology Institute
838
mi
from 43215
Fargo, ND
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
Yale University
537
mi
from 43215
New Haven, CT
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
Yale University
537
mi
from 43215
New Haven, CT
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
University of Indiana
166
mi
from 43215
Indianapolis, IN
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
University of Indiana
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
Status: Enrolling
Updated:  8/3/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
e-Pharmacovigilance II - Surveillance for Safety and Effectiveness - Calling for Earlier Detection of Adverse Reactions
Status: Enrolling
Updated: 8/3/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated:  8/4/2015
University of Rochester, James P. Wilmot Cancer Center
358
mi
from 43215
Rochester, NY
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated: 8/4/2015
University of Rochester, James P. Wilmot Cancer Center
358
mi
from 43215
Rochester, NY
Click here to add this to my saved trials
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated:  8/4/2015
Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Cognitive Behavioral Therapy +/- Armodafinil for Insomnia and Fatigue Following Chemotherapy
Status: Enrolling
Updated: 8/4/2015
Behavioral Sleep Medicine Program, Department of Psychiatry, University of Pennsylvania
414
mi
from 43215
Philadelphia, PA
Click here to add this to my saved trials
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated:  8/4/2015
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Effect of Adenotonsillectomy on Quality of Life in Children With Mild Obstructive Sleep Apnea
Status: Enrolling
Updated: 8/4/2015
Children's Hospital of The King's Daughters
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated:  8/4/2015
Duke University
352
mi
from 43215
Durham, NC
Effect of CPAP on Postoperative Delirium
The Effect of Peri-operative Continuous Positive Airway Pressure (CPAP) on Postoperative Delirium in a Population at High-risk for Obstructive Sleep Apnea (OSA)
Status: Enrolling
Updated: 8/4/2015
Duke University
352
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Acupressure for Persistent Cancer Related Fatigue
Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors
Status: Enrolling
Updated:  8/5/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Acupressure for Persistent Cancer Related Fatigue
Acupressure for Persistent Cancer-Related Fatigue in Breast Cancer Survivors
Status: Enrolling
Updated: 8/5/2015
University of Michigan
164
mi
from 43215
Ann Arbor, MI
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
BryanLGH Heart Institute
718
mi
from 43215
Lincoln, NE
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
BryanLGH Heart Institute
718
mi
from 43215
Lincoln, NE
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Ohio State University
2
mi
from 43215
Columbus, OH
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Lancaster Heart and Stroke Foundation
354
mi
from 43215
Lancaster, PA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Lancaster Heart and Stroke Foundation
354
mi
from 43215
Lancaster, PA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
St. Thomas Heart
332
mi
from 43215
Nashville, TN
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
St. Thomas Heart
332
mi
from 43215
Nashville, TN
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Sentara Cardiovascular Research Institute
422
mi
from 43215
Norfolk, VA
Click here to add this to my saved trials
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated:  8/10/2015
Heart and Diabetes Center
4178
mi
from 43215
Bad Oeynhausen,
Chronic Evaluation of Respicardia Therapy
Safety and Efficacy Evaluation of Respicardia Therapy for Central Sleep Apnea
Status: Enrolling
Updated: 8/10/2015
Heart and Diabetes Center
4178
mi
from 43215
Bad Oeynhausen,
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
VA Connecticut Health Care System
535
mi
from 43215
West Haven, CT
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
VA Connecticut Health Care System
535
mi
from 43215
West Haven, CT
Click here to add this to my saved trials
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated:  8/10/2015
Richard L. Roudebush VA Medical Center
166
mi
from 43215
Indianapolis, IN
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Diagnosis and Treatment of Sleep Apnea in Cerebrovascular Disease
Status: Enrolling
Updated: 8/10/2015
Richard L. Roudebush VA Medical Center
166
mi
from 43215
Indianapolis, IN
Click here to add this to my saved trials
Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated:  8/11/2015
Durham VA Medical Center
351
mi
from 43215
Durham, NC
Treating Co-Morbid Sleep Difficulties in Veterans With Posttraumatic Stress Disorder (PTSD): A Pilot Study
Treating Co-Morbid Sleep Difficulties in Veterans With PTSD: A Pilot Study
Status: Enrolling
Updated: 8/11/2015
Durham VA Medical Center
351
mi
from 43215
Durham, NC
Click here to add this to my saved trials
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Phase IV Study of Bi-Level Positive Positive Airway Pressure (BiPAP)Compared to Nasal Continuous Positive Airway Pressure (CPAP) Therapy
Status: Enrolling
Updated:  8/12/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Auto Bilevel Adherence Following a Poor Initial Encounter With Continuous Positive Airway Pressure (CPAP)
Phase IV Study of Bi-Level Positive Positive Airway Pressure (BiPAP)Compared to Nasal Continuous Positive Airway Pressure (CPAP) Therapy
Status: Enrolling
Updated: 8/12/2015
Brigham and Women's Hosp
643
mi
from 43215
Boston, MA
Click here to add this to my saved trials